Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
https://www.fool.com/investing/2024/06/03/bull-market-buys-2-growth-stocks-to-own-for-the/?source=iedfolrf0000001
Jun 03, 2024 - Innovation is paying off for both of these medical device specialists.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2281956/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2281956
May 31, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Tandem Diabetes (TNDM) Connects Mobi Pump With Dexcom G7 Sensor
https://www.zacks.com/stock/news/2281407/tandem-diabetes-tndm-connects-mobi-pump-with-dexcom-g7-sensor?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2281407
May 30, 2024 - Tandem Diabetes' (TNDM) Mobi insulin pump is now compatible with Dexcom G7 CGM.
0
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2279477/why-dexcom-dxcm-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2279477
May 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
https://www.zacks.com/stock/news/2266232/haemonetics-hae-banks-on-plasma-arm-growth-amid-rising-costs?cid=CS-ZC-FT-analyst_blog|zer_report_update-2266232
May 01, 2024 - Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
0
Here is Why Growth Investors Should Buy DexCom (DXCM) Now
https://www.zacks.com/stock/news/2265356/here-is-why-growth-investors-should-buy-dexcom-dxcm-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2265356
Apr 30, 2024 - DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
0
DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2262800/dexcom-dxcm-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2262800
Apr 25, 2024 - While the top- and bottom-line numbers for DexCom (DXCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
https://www.zacks.com/commentary/2255364/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends?cid=CS-ZC-FT-industry_outlook-2255364
Apr 15, 2024 - The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
0
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
https://www.zacks.com/stock/news/2249369/tenet-thc-divests-six-hospitals-sustains-divestiture-spree?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249369
Apr 02, 2024 - Tenet Healthcare (THC) completes the sale of six California hospitals, four to UCI Health and two to Adventist Health, to refine the portfolio and reduce debt burden.
0
DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2248016/dexcom-dxcm-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2248016
Mar 29, 2024 - DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0